https://www.maximizemarketresearch.com/market-report/global-systemic-lupus-erythematosus-treatment-market/65123/ Systemic Lupus Erythematosus Treatment Market size was valued at US$ 2.72 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 8.59% through 2024 to 2030, reaching nearly US$ 4.85 Bn. Systemic Lupus Erythematosus Treatment Market Overview: Systemic Lupus Erythematosus Treatment Market is expected to reach US$ 4.85 Bn. by 2030. SLE is a systemic autoimmune illness with a widely varied course and prognosis due to a pathological central malfunction in the synthesis of numerous autoantibodies against a variety of self-antigens. B cells play an important role in SLE pathophysiology, and treating the B-cell compartment is the newest trend in current therapeutics. SLE is a type of autoimmune disease that has periods of disease activity and periods of disease quiescence. The major goal of treatment is to keep inflammatory disease activity under control and to avoid lupus flare-ups.